1. The Amplatzer PFO Occluder, developed by Saint Paul, Minn.-based St. Jude Medical, is a new stroke prevention device.
2. New York City-based Tyto Care recently created a digital stethoscope as part of its cloud-based telehealth solution.
3. Hydrocodone bitartrate and acetaminophen tablets are a generic painkiller manufactured by Somerset, N.J.-based Gavis Pharmaceuticals.
4. Dublin-based Medtronic recently developed a “smart defibrillator” that can assess the effectiveness of pulses sent to a patient’s heart and adjust the rate of the pulses accordingly.
5. Vemlidy, manufactured by Foster City, Calif.-based Gilead Sciences, is intended to treat patients with compensated liver disease caused by chronic hepatitis B virus.
6. Intrarosa is a treatment for postmenopausal women who experience moderate to severe pain during sexual intercourse.
More articles on supply chain:
Study: Generic heart drugs vary widely in price, limit access to uninsured patients
Fire in Amazon distribution center forces some retailers to pull products off website
Gavis Pharma earns FDA approval for generic painkiller
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
